11/1/24 |
Novo Nordisk (NVO) |
Semaglutide (NASH) for Non-Alcoholic Steatohepatitis (NASH) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
10/31/24 |
Lexicon Pharmaceuticals (LXRX) |
Inpefa for Diabetes Mellitus, Type I |
Subscribers Only |
Subscribers Only |
Subscribers Only |
10/30/24 |
Corcept Therapeutics (CORT) |
Relacorilant for Cushing's Syndrome |
Subscribers Only |
Subscribers Only |
Subscribers Only |
10/29/24 |
GlycoMimetics (GLYC) |
Uproleselan for Acute Myelogenous Leukemia (AML) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
10/29/24 |
Lexicon Pharmaceuticals (LXRX) |
Inpefa for Diabetes Mellitus, Type I |
Subscribers Only |
Subscribers Only |
Subscribers Only |